• Service: Tax
  • Industry: Infrastructure, Government and Healthcare, Healthcare
  • Type: Publication series, Regulatory update
  • Date: 7/29/2013

China tax and customs planning for R&D activities of China's healthcare & life sciences industry 

China’s healthcare & life sciences industry is currently experiencing significant growth with foreign multinational corporations (MNCs) continuously investing in the Chinese market. The implementation of healthcare reforms by the Chinese government and other regulatory bodies have and will continue to significantly impact business practices and operational costs of companies in this industry.


In our first issue, we highlight common tax and customs matters with an emphasis on R&D activities relating to daily business operations within China’s healthcare & life sciences industry. We also explore potential tax planning ideas to optimise business models for companies in this particular industry with an objective to improve tax efficiency and expedite goods importation.